https://www.selleckchem.com/pr....oducts/trastuzumab-d
he combination, but they should be confirmed in a phase 3 trial in a more homogeneous population (eg, leiomyosarcoma). German Clinical Trials Identifier DRKS00003139. German Clinical Trials Identifier DRKS00003139. The extent to which uveal melanoma is cured by ocular therapy is not known. To estimate cured fractions (CF) of uveal melanoma using combination of institutional and Surveillance, Epidemiology, and End Results (SEER) data. Integrative analysis of 42 years of SEER data (1975-2016) with 25 years (1993-2018) of co